IRIS is rare in people who start treatment with a CD4 cell count above 200. People who develop IRIS usually do so within the first few months of taking anti-HIV medication. Immune reconstitution ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).